drugset / Trial / NCT02556073

ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control

NCT02556073

RandomizedParallel-groupOpen-labelTreatment

Summary

Poor adherence to asthma controller medication may link to poor asthma outcome. A metered dose device with built-in dose counter helps physicians to monitor drug compliance in asthma patients. Mobile-phone based self management opens a window for better asthma control. The present study aims to investigate the relationship between the adherence to controller medication of combined inhaled corticosteroid/long acting beta2-agonists, assessing by integrated dose counter, and the level of airway inflammation and asthma control. Moreover, the investigators also use a new asthma self-management Apps to enhance drug compliance. With the application of the new, easily available tools, the investigator expect to increase adherence rates, and hence, to reduce airway inflammation and improve the level of asthma control.

Timeline

Start
2014-08
Primary completion
2016-08
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Background Fluticasone Other / unclassified 125 ug Inhaled
Background Salmeterol Other / unclassified 25 ug Inhaled

Indications